Journal
DIGESTIVE AND LIVER DISEASE
Volume 53, Issue 2, Pages 183-189Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.dld.2020.10.024
Keywords
COVID-19; SARS-CoV2; Inflammatory bowel disease; Paediatrics
Categories
Ask authors/readers for more resources
The COVID-19 pandemic has impacted medical practices in Italy, particularly affecting the diagnostic and therapeutic management of pediatric chronic diseases, and caution is needed to avoid new epidemic outbreaks.
Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, spreading in Italy during the first months of 2020, abruptly changed the way of practicing medicine in this country. As a consequence of the lockdown, the diagnostic and therapeutic management of paediatric chronic conditions, such as inflammatory bowel disease (IBD) has been affected. During the peak of COVID-19 pandemic, elective visits, endoscopies and infusions have been postponed, with potential clinical and psychological impact on disease course and a high likelihood of increasing waiting lists. While slowly moving back towards normality, clinicians need to recognize the best ways to care for patients with IBD, carefully avoiding risk factors for new potential epidemic outbreaks. In this uncertain scenario until the development and spread of COVID-19 vaccine, it is necessary to continue to operate with caution. Hereby we provide useful indications for a safer and gradual restarting of routine clinical activi-ties after COVID-19 peak in Italy. (C) 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available